Evidence map›Paper›PMID 27269372›Full record

ReviewSeminars in cell & developmental biology2016

Contextual signaling in cancer.

Laura J Smithson, Corina Anastasaki, Ran Chen, Joseph A Toonen, Sidney B Williams, David H Gutmann

Abstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura J SmithsonDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States.
Corina AnastasakiDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States.
Ran ChenDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States.
Joseph A ToonenDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States.
Sidney B WilliamsDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110, United States. Electronic address: gutmannd@wustl.edu.

Funding

BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · NIDA · WASHINGTON UNIVERSITY · PI ARPANA AGRAWAL, Jose A Moron-Concepcion · 1991 to 2026
$8.8M
NERVOUS SYSTEM DEVELOPMENT AND INJURYT32NS007205 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 1985 to 2017
$4.2M
Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma ManagementR01CA195692 · NCI · WASHINGTON UNIVERSITY · PI GUTMANN, DAVID H · 2015 to 2017
$1.7M
NCI NIH HHS R01 CA195692NIDA NIH HHS T32 DA007261NINDS NIH HHS T32 NS007205
6 · The paper itself

Abstract

The formation and maintenance of an organism are highly dependent on the orderly control of cell growth, differentiation, death, and migration. These processes are tightly regulated by signaling cascades in which a limited number of molecules dictate these cellular events. While these signaling pathways are highly conserved across species and cell types, the functional outcomes that result from their engagement are specified by the context in which they are activated. Using the Neurofibromatosis type 1 (NF1) cancer predisposition syndrome as an illustrative platform, we discuss how NF1/RAS signaling can create functional diversity at multiple levels (molecular, cellular, tissue, and genetic/genomic). As such, the ability of related molecules (e.g., K-RAS, H-RAS) to activate distinct effectors, as well as cell type- and tissue-specific differences in molecular composition and effector engagement, generate numerous unique functional effects. These variations, coupled with a multitude of extracellular cues and genomic/genetic changes that each modify the innate signaling properties of the cell, enable precise control of cellular physiology in both health and disease. Understanding these contextual influences is important when trying to dissect the underlying pathogenic mechanisms of cancer relevant to molecularly-targeted therapeutics.

Indexed as

Signal TransductionAnimalsGenetic LociHumansModels, BiologicalMutationNeoplasmsras Proteinsras ProteinsAstrocyteGliomamTORNervous systemNeuronNF1RAS

Identifiers

PMID27269372
PMCPMC5028257

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.